Tuesday, December 7, 2021

Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients

A recent phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.

from Top Health News -- ScienceDaily https://ift.tt/3Is7pm2
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Study finds untreated sleep apnea doubles Parkinson’s risk

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lowe...